Short answer · Medically reviewed summary · Last updated: 2026-05-08
CHARGE syndrome is a complex, multisystem genetic condition that typically presents at birth with a specific set of physical features, including eye abnormalities, heart defects, and hearing loss. It is primarily caused by mutations in the CHD7 gene, which plays a critical role in the early development of many organ systems. What are the primary symptoms of CHARGE syndrome? The name CHARGE syndrome is an acronym that summarizes the clinical features historically used to diagnose the condition: Coloboma (eye defects), Heart defects, Atresia of the choanae (blocked nasal passages), Retardation of growth and development, Genital abnormalities, and Ear abnormalities.
CHARGE syndrome is a complex, multisystem genetic condition that typically presents at birth with a specific set of physical features, including eye abnormalities, heart defects, and hearing loss. It is primarily caused by mutations in the CHD7 gene, which plays a critical role in the early development of many organ systems.
The name CHARGE syndrome is an acronym that summarizes the clinical features historically used to diagnose the condition: Coloboma (eye defects), Heart defects, Atresia of the choanae (blocked nasal passages), Retardation of growth and development, Genital abnormalities, and Ear abnormalities. While these are the hallmark signs, individuals with CHARGE syndrome may also experience cranial nerve dysfunction, which can lead to difficulties with swallowing, facial movement, or balance.
CHARGE syndrome is a rare disorder with an estimated birth prevalence ranging from 1 in 8,500 to 1 in 15,000 live births worldwide. It affects males and females equally, and there is no known geographic, ethnic, or racial predisposition. Because it is a developmental condition, the diagnosis is almost always made during the newborn period or early infancy, though milder cases may occasionally be identified later in childhood.
In approximately 65% to 70% of clinical cases, CHARGE syndrome is caused by a mutation in the CHD7 gene. This gene provides instructions for making a protein that regulates gene expression during embryonic development. Most cases occur sporadically as a "de novo" mutation, meaning it is not inherited from the parents, though genetic counseling is essential to assess recurrence risks for future pregnancies.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.